Failure to Achieve a Threshold Dose of CD34+CD110+ Progenitor Cells in the Graft Predicts Delayed Platelet Engraftment after Autologous Stem Cell Transplantation for Multiple Myeloma-Reference-Cited by-同舟云学术

Failure to Achieve a Threshold Dose of CD34+CD110+ Progenitor Cells in the Graft Predicts Delayed Platelet Engraftment after Autologous Stem Cell Transplantation for Multiple Myeloma

Published:2009-11 Issue:11 Volume:15 Page:1386-1393
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Wallington-Beddoe Craig T.,Gottlieb David J.,Garvin Fran,Antonenas Vicki,Sartor Mary M.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference17 articles.

1. Multiple myeloma;Kyle;Blood,2008

2. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroup Francophone du Myelome;Attal;N Engl J Med,1996

4. Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis;Kumar;Am J Hematol,2008

5. Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma;Qazilbash;Bone Marrow Transplant,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal haematopoiesis of indeterminate potential predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma;British Journal of Haematology;2023-03-07

2. Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosis;Bone Marrow Transplantation;2022-04-02

3. Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation;Transplantation and Cellular Therapy;2021-05

4. Adequate Engraftment With Lower Hematopoietic Stem Cell Dose;Clinical Lymphoma Myeloma and Leukemia;2020-04

5. Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients;Hematology/Oncology and Stem Cell Therapy;2020-03